India Over the Counter Drugs Market Overview 2024-2032
The latest report by IMARC Group, titled “India Over the Counter Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032“, offers a comprehensive analysis of the industry, which comprises insights on the market share. The India over the counter (OTC) drugs market size reached US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 29.6 Billion by 2032, exhibiting a growth rate (CAGR) of 14.28% during 2024-2032.
Over-the-counter (OTC) drugs are medications that are available for purchase without a prescription from a healthcare professional. These drugs are typically used to treat common ailments and minor health issues, such as headaches, colds, allergies, and minor aches and pains. OTC drugs can be obtained directly from pharmacies, grocery stores, and other retail outlets, and are regulated by government agencies, such as the Food and Drug Administration (FDA) in the United States, to ensure their safety and efficacy for consumer use.
Additionally, manufacturers of OTC drugs must adhere to strict guidelines regarding their ingredients, labeling, and marketing to ensure that consumers can use them safely and effectively without the guidance of a healthcare provider. Some commonly known OTC drugs include pain relievers such as acetaminophen and ibuprofen, antihistamines for allergies, cough, and cold medications, antacids for heartburn and indigestion, and topical treatments for skin conditions including acne and minor cuts and burns. Nowadays, OTC drugs are convenient for managing minor health issues without a doctor’s visit.
India Over the Counter Drugs Market Trends and Drivers:
The India over-the-counter (OTC) drugs market is primarily driven by the rising prevalence of minor health issues and self-medication practices among the population is escalating the demand for OTC drugs. Additionally, with the increasing awareness about common ailments and the convenience of accessing OTC medications without a prescription, consumers are opting for these products for quick relief from symptoms.
Moreover, the growing middle-class population with higher disposable incomes is escalating the demand for OTC drugs as they seek affordable and accessible healthcare solutions. Furthermore, the government initiatives to improve healthcare infrastructure and promote self-care are also contributing to market growth. Along with this, regulatory reforms aimed at streamlining the approval process for OTC drugs and ensuring their safety and efficacy are bolstering consumer confidence in these products.
Besides this, the widespread penetration of e-commerce platforms has made OTC drugs more accessible to consumers, especially in remote areas with limited access to traditional brick-and-mortar pharmacies. Besides this, the COVID-19 pandemic has further accelerated the growth of the OTC drugs market in India, with consumers increasingly turning to these medications for managing mild symptoms and reducing the burden on healthcare facilities. Furthermore, the growing preference for natural and herbal OTC remedies due to their perceived safety and efficacy is expanding the product offerings in the market, thus creating a positive market outlook across the globe.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/india-over-the-counter-drugs-market/requestsample
India Over the Counter Drugs Market 2024-2032 Analysis and Segmentation:
The report segmented the market on the basis of region, product type, route of administration, dosage form and distribution channel.
Product Type Insights:
- Cough, Cold and Flu Products
- Analgesics
- Dermatology Products
- Gastrointestinal Products
- Vitamins, Minerals and Supplements (VMS)
- Weight-loss/Dietary Products
- Ophthalmic Products
- Sleeping Aids
- Others
Route of Administration Insights:
- Oral
- Parenteral
- Topical
- Others
Dosage Form Insights:
- Tablets and Capsules
- Liquids
- Ointments
- Others
Distribution Channel Insights:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Region Insights:
- North India
- West and Central India
- South India
- East India
Key highlights of the report:
- Market Performance (2018-2023)
- Market Outlook (2024- 2032)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163